Cyberlux and OKSI Advance UAS Capabilities for GPS- and RF-Denied Environments

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cyberlux Corporation (OTC: CYBL), a leading provider of advanced defense technologies, is pleased to announce a strategic partnership with OKSI (Optical Knowledge Systems, Inc.) to enhance unmanned aerial system (UAS) operations in GPS- and radio frequency (RF)-denied environments.
This collaboration integrates OKSI's cutting-edge OMNISCIENCE™ autonomy suite into Cyberlux's latest UAS platforms, delivering robust navigation and target acquisition capabilities without reliance on traditional GPS or RF communications. Key features include:
OMNInav: A GPS-denied navigation module providing precise, drift-free positioning through multi-modal sensor fusion.
OMNIseek: Advanced automatic target detection and recognition, enabling rapid identification of targets in complex environments.
OMNIlocate: Provides Category I/II target coordinates in denied environments, facilitating accurate targeting.
OMNItarget: Offers terminal guidance capabilities for precision engagement.
These integrated systems are designed to support sustained operations in contested areas where GPS and RF signals are compromised, ensuring mission success through autonomous decision-making and adaptability.
'This partnership with OKSI represents a critical advancement in our mission to deliver next-generation autonomous capabilities to the warfighter,' said Mark Schmidt, CEO of Cyberlux Corporation. 'By integrating OKSI's OMNISCIENCE™ suite into our UAS platforms, we are enabling reliable operations in the most challenging, signal-denied environments and redefining the tactical edge of unmanned systems.'
Cyberlux and OKSI anticipate initial product demonstrations in Q3 2025, showcasing the enhanced UAS capabilities to potential defense and commercial clients.
About Cyberlux Corporation
Cyberlux Corporation is a leading provider of advanced defense technologies, specializing in unmanned aerial systems, tactical lighting solutions, and innovative technologies designed to meet the needs of military, government, and commercial clients.
About OKSI
OKSI (Optical Knowledge Systems, Inc.) is at the forefront of artificial intelligence and optical system innovation, delivering advanced solutions in navigation, target recognition, and decision-making across diverse operational scenarios.
For more information, please visit www.cyberlux.com.
SAFE HARBOR STATEMENT
This Press Release may contain forward-looking statements that can be identified by terminology such as 'believes,' 'expects,' 'potential,' 'plans,' 'suggests,' 'may,' 'should,' 'could,' 'intends,' or similar expressions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's OTC/SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Wire

40 minutes ago

• Business Wire

Ennis, Inc. Reports Results for the Quarter Ended May 31, 2025 and Declares Quarterly Dividend

MIDLOTHIAN, Texas--(BUSINESS WIRE)--Ennis, Inc. (the 'Company'), (NYSE: EBF), today reported financial results for the first quarter ended May 31, 2025. Highlights include: Financial Overview The Company's revenues for the first quarter ended May 31, 2025 were $97.2 million compared to $103.1 million for the same quarter last year, a decrease of $5.9 million, or 5.7%. Gross profits totaled $30.2 million for a gross profit margin of 31.1%, as compared to $30.9 million, or 30.0%, for the same quarter last year. Net earnings for the quarter were $9.8 million, or $0.38 per diluted share, as compared to $10.7 million, or $0.41 per diluted share for the same quarter last year. Keith Walters, Chairman, Chief Executive Officer and President, commented by stating, 'Our performance for the quarter met our expectations. Although there was a year-over-year decline in sales, our gross profit margin increased to 31.1% for the quarter compared to 30.0% for the same quarter last year and 29.5% for the fourth quarter. Our EBITDA increased to $17.7 million or 18.2% of sales for the current quarter compared to the preceding quarter of $16.5 million or 17.8% of sales and declined slightly compared to the same quarter last year from $19.0 million or 18.4% of sales. Our ability to maintain or improve our profit margins amidst decreased market demand highlights the success of our cost management and pricing discipline. 'Our recent acquisitions generated approximately $5.5 million in revenues during the quarter and positively impacted diluted earnings per share by $0.035. Midway through the quarter, we acquired Northeastern Envelope ('NEC') located in Old Forge, PA. NEC is a large commercial manufacturer of envelopes and offers next day shipment of hundreds of double window and special single window envelopes. Printing Technologies, Inc. ("PTI") acquired during the second quarter of the prior year has been fully integrated in the Ennis ERP systems and is performing well. 'Recently, the sole mill in the United States that produces carbonless paper announced that it would be closing this calendar year. In preparation for that supply disruption, we invested in and are continuing to purchase additional inventory as a buffer as we pivot to other sources of carbonless paper. The additional investment in inventory, our purchase of NEC and our share repurchases this quarter have reduced our cash balances, such that our interest income for the quarter declined to $0.6 million compared to $1.4 million for the same quarter last year. 'We continue to maintain a strong financial position with $32.0 million in cash and no debt. We repurchased 260,560 shares of our common stock in the open market at an average price of $19.00 per share. Our profitability and strong financial condition will allow us to fund our operations and routine acquisitions without incurring debt. Given those strengths, we also anticipate timely access to credit should larger acquisition opportunities materialize. We continue to focus on returning value to shareholders by delivering profitability and through our quarterly dividends.' Reconciliation Non-GAAP Measure To provide important supplemental information to both management and investors regarding financial and business trends used in assessing its results of operations, from time to time the Company reports the non-GAAP financial measure of EBITDA (EBITDA is calculated as net earnings before interest expense, tax expense, depreciation, and amortization). The Company may also report adjusted gross profit margin, adjusted earnings and adjusted diluted earnings per share, each of which is a non-GAAP financial measure. Management believes that these non-GAAP financial measures provide useful information to investors as a supplement to reported GAAP financial information. Management reviews these non-GAAP financial measures on a regular basis and uses them to evaluate and manage the performance of the Company's operations. Other companies may calculate non-GAAP financial measures differently than the Company, which limits the usefulness of the Company's non-GAAP measures for comparison with these other companies. While management believes the Company's non-GAAP financial measures are useful in evaluating the Company, when this information is reported it should be considered as supplemental in nature and not as a substitute or an alternative for, or superior to, the related financial information prepared in accordance with GAAP. These measures should be evaluated only in conjunction with the Company's comparable GAAP financial measures. The following table reconciles EBITDA, a non-GAAP financial measure, for the three-months ended May 31, 2025 and 2024 to the most comparable GAAP measure, net earnings (dollars in thousands). In Other News On June 20, 2025 the Board of Directors declared a quarterly cash dividend of 25.0 cents per share on the Company's common stock. The dividend is payable on August 11, 2025 to shareholders of record on July 11, 2025. About Ennis Founded in 1909, the Company is one of the largest private-label printed business product suppliers in the United States. Headquartered in Midlothian, Texas, Ennis has production and distribution facilities strategically located throughout the USA to serve the Company's national network of distributors. Ennis manufactures and sells business forms, other printed business products, printed and electronic media, integrated forms and labels, presentation products, flex-o-graphic printing, advertising specialties, internal bank forms, plastic cards, secure and negotiable documents, specialty packaging, direct mail, envelopes, tags and labels and other custom products. For more information, visit Safe Harbor under the Private Securities Litigation Reform Act of 1995 Certain statements that may be contained in this press release that are not historical facts are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors that could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievement expressed or implied by such forward-looking statements. The words 'anticipate,' 'preliminary,' 'expect,' 'believe,' 'intend' and similar expressions identify forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for such forward-looking statements. In order to comply with the terms of the safe harbor, the Company notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These statements are subject to numerous uncertainties, which include, but are not limited to, the erosion of demand for our printer business documents as the result of digital technologies, risk or uncertainties related to the completion and integration of acquisitions, and the limited number of available suppliers and variability in the prices of paper and other raw materials. Other important information regarding factors that may affect the Company's future performance is included in the public reports that the Company files with the Securities and Exchange Commission, including but not limited to, its Annual Report on Form 10-K for the fiscal year ending February 28, 2025. The Company does not undertake, and hereby disclaims, any duty or obligation to update or otherwise revise any forward-looking statements to reflect events or circumstances occurring after the date of this release, or to reflect the occurrence of unanticipated events, although its situation and circumstances may change in the future. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statement are material.

Newsweek

42 minutes ago

• Newsweek

AI Impact Awards 2025: How 7 Health Care Winners Measure Impact

Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Artificial intelligence is an all-consuming force in the health care industry—and it's still gaining momentum. In 2024, the global health care AI market was estimated at more than $26 billion, and it's expected to grow to over $187 billion by 2030. There's good reason for the boom. Health care executives, physicians and tech leaders alike agree that AI has enormous potential in the industry. It can help make outdated processes more efficient, generate new meaning from massive pools of data and even improve communications between industry stakeholders. But as the AI market grows, it's becoming more challenging for health systems to parse through the noise and find solutions that will actually improve care outcomes. Newsweek spoke with health care and life sciences winners of our inaugural AI Impact Awards to determine how they define and measure impact. Health care and life sciences were just one of the industries represented, and across more than a dozen categories, there were 38 total winners were selected by a panel of AI and subject matter experts. Here's how seven award-winning companies distinguish their AI models from the hype cycle: Several health care companies received AI Impact awards for their significant contributions to the industry. Several health care companies received AI Impact awards for their significant contributions to the industry. Newsweek Illustration AI Health Care, Best Outcomes, Care Coordination – Xsolis Xsolis has created a suite of AI solutions to better connect health care providers with payer organizations and health plans. It serves more than 500 hospitals and health systems and 18 health plans nationwide—and is rapidly expanding its market share, securing spots on the Inc. 5000 and the Deloitte Tech Fast 500 for the fastest growing private companies. To measure impact, Xsolis tracks the number of cases that are denied and overturned by insurance companies, according to Dr. Heather Bassett, the company's chief medical officer. "We're able to show our clients, through the use of our AI and other analytics, that they were able to appropriately capture revenue based on the medical intensity of their patient population," Bassett told Newsweek. "Today, we're at about $1.5 billion that we've either protected or helped our clients appropriately capture [across our company's lifetime]." Since most hospitals are understaffed, they aren't always able to fight every claim and maximize their reimbursements, she added. Xsolis' tool boosts the efficiency of utilization management teams by approximately 20 percent, allowing them to review a larger share of cases. AI Health Care, Best Outcomes, Health Equity – Bunkerhill Health "For us, it's actually fairly easy to quantify impact," Nishith Khandwala, co-founder and CEO of Bunkerhill Health, told Newsweek. The company uses AI to identify clinically significant findings that are hidden in patient records, and ensure that patients receive the follow-up care they need to prevent future complications. For example, a patient might get into a car accident and receive a CT scan to check for cracked ribs. The CT scan might also find signs of coronary artery disease—but in today's medical system, those findings would never be flagged because they weren't relevant to the car crash. Bunkerhill Health tracks success by counting the number of patients that it flags for a separate encounter with a specialist, like a cardiologist or an oncologist. "In our office, we have a counter," Khandwala said. "Every time we find a patient who we discovered to have high risk for some other problem, we increment that counter, because that's the number of lives that we have impacted." AI Health Care, Best Outcomes, Patient Care – Cera Based in the United Kingdom, Cera is harnessing technology and AI to predict and prevent avoidable falls and hospitalizations in the elderly population. Its ecosystem includes a proprietary app that allows health care staff, patients and families to log health indicators in real time, along with two AI models. The first, Falls Prevention AI, predicts 83 percent of falls up to seven days in advance—allowing health care staff to intervene and prevent the leading cause of hospitalizations in adults over age 65. The second, its Hospitalization Predict-Prevent tool, predicts three-quarters of hospitalizations one week in advance. Together, the pair of AI tools flag up to 5,000 high-risk alerts each day, according to Cera founder and CEO Dr. Ben Maruthappu. Data like this shows the impact that the tools are having on patient safety (and on the U.K.'s health system, which spends over £2.3 billion per year on falls in the over-65 population). "Most importantly of all, we are using AI to make an impact at scale," Maruthappu told Newsweek. "Cera works with over a hundred U.K. Local Governments and the majority of NHS regions, reducing costs, transforming life for patients, and bringing healthcare services into the future." AI Health Care, Best Outcomes, Diagnostics – Color Health Color Health is the largest virtual cancer clinic in the United States, created in partnership with the American Cancer Society. Last summer, it teamed up with OpenAI to develop its Cancer Copilot: a novel AI architecture that creates accurate clinical recommendations for clinicians, expanding access to world-class oncology expertise for doctors working at major cancer centers, small community health facilities and every setting in between. The company primarily charts AI impact in two ways, co-founder and CEO Othman Laraki told Newsweek. First, it tracks how much time clinicians save by using the AI tool. Traditionally, nurses and oncologists had to spend 1-2 hours looking through a patient chart and determining how to prepare them for treatment, Laraki said. Using AI, they can craft the same plan in just 15 minutes. Additionally, Color Health measures how, when and why clinicians opt to change the output of the AI model. The company's most recent data shows that physicians choose to make changes in less than two percent of the clinical decision factors suggested by the model. Most of those changes had to do with formatting, Laraki added; the model has an error rate under one percent. "It's performing way better than anything that we've seen published so far," Laraki said. "And it's not because we're using better models—we're using standard open AI release models—but it's because of this architecture that makes the model behave in a very predictable way." AI Health Care, Best Outcomes, Physician Satisfaction – Iodine Software At Iodine Software, impact is measured in reimbursement gains, along with improvements in productivity and physician satisfaction, according to co-founder and CEO William Chan. The company utilizes AI to automate the middle of the revenue cycle, which traditionally requires nurses and physicians to manually collect, interpret and analyze patient data. By inserting AI into the process, Iodine Software paints a more complete clinical picture for insurance companies, ultimately resulting in fewer denials and more accurate reimbursements to health systems. Across all of Iodine's 1,000 hospital clients, that rightsizing yields a cumulative $2.4 billion per year, Chan told Newsweek. Iodine Software also saves time for health care providers, cutting the time spent reviewing patient case records by "at least half," Chan said. Since the AI model presents information in a concise, precise and actionable way, physicians can respond to information requests more quickly. Clarification asks that once took three days to answer have been whittled down to two hours, in some instances. "Physicians love that interaction compared to what it was previously," Chan said. Best of – Most Innovative AI Technology or Service, Extraordinary Impact in AI Innovation – Phare Bio In 2020, researchers at the Collins Lab at MIT made a landmark discovery when they used AI to identify a new class of antibiotics. Phare Bio was born from that breakthrough, and has since leveraged AI to uncover two additional novel antibiotic classes. The company's model prioritizes the superbugs identified as the most dangerous by the CDC and the WHO, and predicts drug efficacy, toxicity and pharmacokinetics with high accuracy. Phare Bio has also developed AIBiotics, a generative AI platform that designs new antibiotics. Ultimately, the company aims to improve the efficiency of antibiotic research and development, according to Dr. Akhila Kosaraju, its president and CEO. How does it measure that? Ultimately, by "taking better and fewer shots on goal," Kosaraju told Newsweek. It often costs between $1.3 and $1.5 billion to get a single drug over the finish line for FDA approval. "Those numbers are so high [because they] encompass all of the failures along the way to get to that one exceptional drug," Kosaraju said. "If we can reduce the number of shots on goal substantially, we can half or quarter the cost and time to get these drugs into clinical trials, and then ultimately to be FDA-approved." AI Education, Best Outcomes, Higher Education – MedCerts MedCerts has integrated conversational AI, generative AI and natural language processing into its training programs for health care and IT students. Now, students can interact with virtual patients who respond and adapt to their input in real time. One of the company's major innovations was an in-house AI program for certified nursing assistants (CNAs), designed to develop and assess soft skills like empathy, communication and problem-solving. Traditionally, these skills have been tough to measure—but with MedCerts' AI model, students can practice responding to high-pressure situations in a safe, yet nuanced environment. Student engagement is a primary indicator of an educational tool's impact, according to Dana Janssen, MedCerts' chief product officer. AI has enabled the company to give students a more interactive experience and bolster their chances of success. "One of the biggest KPIs for us is program completion, because you can't get certified and you can't get a job without first completing your programs," Janssen told Newsweek. "The more engaging we can make our content or our training—the more interactive—the more effective it ultimately is." To see the full list of AI Impact winners, visit the official page for Newsweek's AI Impact Awards. Newsweek will continue the conversation on meaningful AI innovations at our AI Impact Summit from June 23 to 25 in Sonoma, California. Click here to follow along on the live blog.

Business Upturn

an hour ago

• Business Upturn

Building Thermal Insulation Market worth $37.0 billion by 2028, at 4.8%, says MarketsandMarkets™

By GlobeNewswire Published on June 23, 2025, 13:30 IST Delray Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) — In terms of value, the Building Thermal Insulation Market size was estimated at USD 29.2 billion in 2023 and is projected to reach USD 37.0 billion by 2028, at a CAGR of 4.8%, as per the recent study by MarketsandMarkets™. The increasing need for green buildings to combat global warming drives the demand for insulation materials in residential and non-residential buildings. Stringent regulations on reducing greenhouse gas emissions and increasing investments in net-zero energy or low carbon buildings are expected to drive the building thermal insulation market. Download PDF Brochure: Browse in-depth TOC on 'Building Thermal Insulation Market' 311 – Market Data Tables 64 – Figures 262 – Pages List of Key Players in Building Thermal Insulation Market: Kingspan Group PLC (UK) Knauf Gips KG (Germany) Owens Corning (US) Rockwool A/S (Denmark) Saint-Gobain SA (France) BASF SE (Germany) Dow Inc. (US), Johns Manville Corporation (US) GAF Materials Corporation (US) CNBM Group Co., Ltd. (China) Drivers, Opportunities and Challenges in Building Thermal Insulation Market: Drivers: Stringent environmental regulations Restraint: Fluctuation in prices of plastic foam Opportunity: High energy requirements Challenge: Lack of awareness on building thermal insulation Get Sample Pages: Key Findings of the Study: The plastic foam segment to account for largest share in the building thermal insulation market, in terms of value, during the forecast period. Wall insulation to lead building thermal insulation market in application, during the forecast period, in terms of value. Residential segment to lead building thermal insulation market in building type segment, during the forecast period, in terms of value. Europe is expected to be the fastest-growing region, in the overall building thermal insulation market, during the forecast period. Based on material, the building thermal insulation market is segmented as Glass Wool, Stone Wool, and Plastic Foam. Plastic foam was the largest segment in global building thermal insulation market, in terms of value, in 2022. This is mainly due to its high thermal resistance (R-Value), versatility, strength, and life span. The long-life cycle of plastic foam insulation leads to its usage in applications such as walls, floors, and roofs. Its high thermal resistance, versatility, strength, and life span emphasize the need of plastic foam in the building thermal insulation market. Based on building type, the building thermal insulation market is segmented as residential, and non-residential. Notably, the residential segment emerged as the market leader in 2022 and is anticipated to maintain its dominant position through 2028. Factors such as changing consumer preferences, sustainability imperatives, regulatory dynamics, and technological advancements of materials with exceptional insulating qualities and environmental friendliness have contributed to the residential segment's leadership in the building thermal insulation market. Get Customization on this Report: Based on application, the building thermal insulation market is segmented as roof insulation, floor insulation, and wall insulation. Wall insulation is estimated to be the largest application for building thermal insulation market, in terms of value, during the forecast period. The dominance is due to the increasing use of insulation for blankets, concrete blocks, foam boards, insulating concrete form, and structural insulated panels. The rising energy efficient buildings drive the demand for wall insulation in building thermal insulation market. Based on region, Europe stands out as the fastest growing market for building thermal insulation. Europe's dominance in the building thermal insulation market has been largely driven by technological innovation. The region is home to research and development centers as well as a bustling startup and innovation community that is concentrated on sustainable solutions. The market for building thermal insulation grew due to the growth in construction activities and the ease of recyclability of used building thermal insulation materials, leading to a substantial expansion of the building thermal insulation market in Europe. Browse Adjacent Markets Foam and Insulation Market Research Reports Related Reports: Metal Recycling Market Wood Coatings Market Synthetic Rope Market Sodium Silicate Market Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.